The development of an in vitro method to measure the sensitivity of tumour cells to cytotoxic drugs, so that the most effective drugs may be chosen for treatment is a major goal in cancer chemotherapy. A number of authors have reported that colony-forming assays appeared to be the most reliable dose-dependent index of cell lethality in vitro, and that other methods, such as dye exclusion, were inadequate to measure drug-induced cytotoxicity (Bhuyan et al., 1976; Roper & Drewinko, 1976; Rupniak et al., 1983) . More recently, however, an assay based on dye-exclusion, the differential staining cytotoxicity (DiSC) assay, has been developed which overcomes many of the theoretical and technical pitfalls inherent in traditional dye-exclusion methods (Bird et al., 1985 (Bird et al., , 1986 Weisenthal et al., 1983a Weisenthal et al., , 1984 . The biological and clinical validity of this assay have been demonstrated for a number of primary solid and haematological tumour types (Bird et al., 1985 (Bird et al., , 1986 Weisenthal et al., 1984) , and the theoretical basis of the assay has recently been carefully assessed (Weisenthal & Lippman, 1985 (Bird et al., 1986) . Drugs were incubated for I h at 37°C with cells harvested in logarithmicphase growth.
The DiSC assay was performed (in Bath) as previously described (Bird et al., 1985) but using 103-2 x 104 cells in 1 ml of RPMI-FCS. Briefly, after drug exposure, cells were incubated at 37°C for 4 days. Following this, the cells were stained with nigrosin-fast green containing a known number of fixed duck red blood cells (DRBC) and cytocentrifuged onto collagen-coated slides. The slides were fixed and counterstained with a Romanowsky stain. The ratio of live cells over DRBC was determined for each slide, and the ratio in drug-treated samples expressed as a percentage of that in the control.
For the colony-forming assay (performed in Bristol), the same number of cells were plated in a 1 ml upper layer of 0.3% agar in RPMI-FCS over a base layer of 0.5% agar in the same medium. Colonies were counted at 10-14 days. Cloning efficiencies were approximately 85%, 4% and 5% for the K562, HL60 and MOLT-4 cell lines respectively. Dose response curves were constructed from 2 or 3 experi- ments. Three plates were set up for each drug concentration within each experiment. The dose-response curves were compared at the end of the study. The cell lines for the two assays were obtained from the same source but grown separately at the two study centres. Figures 1-3 show the effect of a 1 h drug-exposure of each of the 4 drugs studied on K562, HL60 and MOLT-4 cells respectively. Both the DiSC assay and the colony-forming assay showed a clear dose response relationship for all drugs tested. For the non-phase specific drugs vincristine, 4-hydroperoxycyclophosphamide (4-HC) and adriamycin, the DiSC assay gave either an equal or a lower estimate of cell kill, with drug concentrations at the LD50 between 0.8 and 12 times higher than for the colony-forming assay. In contrast, the phase-specific drug cytarabine showed higher cell kill in the DiSC assay and drug concentrations at the LD50 4-10 times lower.
A number of investigators have shown little or no cell kill with traditional dye-exclusion assays at drug concentrations giving a clear dose-response relationship with the colonyforming assay (Roper & Drewinko, 1976; Rupniak et al., 1983) . Weisenthal et al. (1983b) suggested that this failure of dye-exclusion assays to accurately reflect the reproductive capacity of tumour cell populations was probably due to a number of pitfalls associated with earlier assays of this type. The DiSC assay has been developed to overcome these pitfalls, and includes significant modifications from traditional dye-exclusion methods which give it a far better theoretical basis (Weisenthal & Lippman, 1985) .
In this study we have tested the ability of the DiSC assay to assess cytotoxicity, and to determine whether the index of early loss of viability correlates with the loss of reproductive potential. A 1 h drug exposure was used to ensure that cytotoxic rather than cytostatic effects were measured. One drug from each of four different classes of anti-tumour agents was employed including both cell cycle phase specific and non-specific drugs. The results obtained indicate that the cytotoxicities of drugs with widely differing mechanisms of action are able to be assessed with the DiSC assay, in contrast to traditional dye-exclusion assays. The DiSC assay therefore represents a considerable improvement over such assays.
We have shown the colony-forming assay to be generally more sensitive to the drugs tested that are not strictly phase specific, whilst with cytarabine, the DiSC assay has shown a greater sensitivity. This latter result, together with a similar finding of Weisenthal and colleagues (1983b) Ara C concentration (j±g ml-') Adr concentration (ng ml-') show similar accuracy (Weisenthal & Lippman, 1985) , indicating that neither method is superior to the other. The DiSC assay is a relatively simple in vitro drug sensitivity assay that is capable of being easily performed by hospital haematology staff, and does not use radioactive materials or complicated procedures. To this end, we believe that the DiSC assay has much to offer as a routine drugsensitivity test, and that its role in the prediction of tumour response to chemotherapy should be further evaluated.
